Skip to main content
Study

Association of adverse events in opioid addiction treatment with quality measure for continuity of pharmacotherapy.

Liu Y, Becker A, Mattke S. Association of adverse events in opioid addiction treatment with quality measure for continuity of pharmacotherapy. J Healthc Qual. Epub 2022 Jan 27. doi: 10.1097/jhq.0000000000000338

Save
Print
February 16, 2022
Liu Y, Becker A, Mattke S. J Healthc Qual. 2022;44(3):e38-e43.

Medication-assisted treatment (MAT) is increasingly used to treat opioid use disorder (OUD). This study found that providers or practices with higher quality measure scores of MAT continuity (percentage of patients with OUD who had at least 180 days of continuous treatment) had a lower risk of opioid-related adverse events among their patients.

Save
Print
Cite
Citation

Liu Y, Becker A, Mattke S. Association of adverse events in opioid addiction treatment with quality measure for continuity of pharmacotherapy. J Healthc Qual. Epub 2022 Jan 27. doi: 10.1097/jhq.0000000000000338